Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors

Gene Therapy volume 23, pages 815–818 (2016)Cite this article

Subjects

Abstract

Integrating vectors based on γ-retroviruses and containing full-length long terminal repeats (LTRs) have been associated with activation of oncogene expression and leukemogenesis in human gene therapy trials. Identification of the specific molecular elements of the LTRs that have a role in insertional oncogenesis events is important as it can lead to the development of safer gene transfer vectors. The negative control region (NCR) of the LTR is a particularly well-conserved sequence among mammalian γ-retroviruses with demonstrated regulatory activity of gene transcription in hematopoietic cells, which led us to hypothesize that this region may have a role in insertional oncogenesis after γ-retroviral vector (GV)-mediated gene transfer into hematopoietic progenitors. We used an in vitro assay of murine bone marrow cell immortalization to compare the immortalization capabilities of a series of GVs carrying murine leukemia virus (MLV) LTR deletion mutants. Compared with GV carrying the full-length MLV LTR, deletion of the complete LTR enhancer sequence showed significant reduction of immortalization rates. However, the use of a mutant LTR deleted of the enhancer sequence, with exception of the NCR, did not affect immortalization. Importantly, the inclusion of an LTR mutant devoid only of the NCR did show significant reduction of immortalization rates compared with the full LTR sequence. Therefore, our data point to the NCR as a key element for immortalization and justify additional studies to evaluate its specific role in MLV-mediated insertional oncogenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Kang EM, Choi U, Theobald N, Linton G, Long Priel DA, Kuhns D et al. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 2010; 115: 783–791.

    Article  CAS  Google Scholar 

  2. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010; 363: 355–364.

    Article  CAS  Google Scholar 

  3. Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C et al. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood 2012; 120: 3635–3646.

    Article  CAS  Google Scholar 

  4. Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M et al. Gene therapy for wiskott-Aldrich syndrome—ong-term efficacy and genotoxicity. Sci Transl Med 2014; 6: 227ra33.

    Article  Google Scholar 

  5. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–419.

    Article  CAS  Google Scholar 

  6. Bosticardo M, Ghosh A, Du Y, Jenkins NA, Copeland NG, Candotti F . Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells. Mol Ther 2009; 17: 1910–1918.

    Article  CAS  Google Scholar 

  7. McBurney MW, Sutherland LC, Adra CN, Leclair B, Rudnicki MA, Jardine K . The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res 1991; 19: 5755–5761.

    Article  CAS  Google Scholar 

  8. Flanagan JR, Krieg AM, Max EE, Khan AS . Negative control region at the 5' end of murine leukemia virus long terminal repeats. Mol Cell Biol 1989; 9: 739–746.

    Article  CAS  Google Scholar 

  9. Wahlers A, Zipfel PF, Schwieger M, Ostertag W, Baum C . In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity. J Virol 2002; 76: 303–312.

    Article  CAS  Google Scholar 

  10. Tsukiyama T, Ueda H, Hirose S, Niwa O . Embryonal long terminal repeat-binding protein is a murine homolog of FTZ-F1, a member of the steroid receptor superfamily. Mol Cell Biol 1992; 12: 1286–1291.

    Article  CAS  Google Scholar 

  11. Wahlers A, Kustikova O, Zipfel PF, Itoh K, Koester M, Heberlein C et al. Upstream conserved sequences of mouse leukemia viruses are important for high transgene expression in lymphoid and hematopoietic cells. Mol Ther 2002; 6: 313–320.

    Article  CAS  Google Scholar 

  12. Wang L, Haas D, Halene S, Kohn DB . Effects of the negative control region on expression from retroviral LTR. Mol Ther 2003; 7: 438–440.

    Article  CAS  Google Scholar 

  13. Trobridge GD, Miller DG, Jacobs MA, Allen JM, Kiem HP, Kaul R et al. Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci USA 2006; 103: 1498–1503.

    Article  CAS  Google Scholar 

  14. Uchiyama T, Adriani M, Jagadeesh GJ, Paine A, Candotti F . Foamy virus vector-mediated gene correction of a mouse model of Wiskott–Aldrich syndrome. Mol Ther 2012; 20: 1270–1279.

    Article  CAS  Google Scholar 

  15. Beard BC, Keyser KA, Trobridge GD, Peterson LJ, Miller DG, Jacobs M et al. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum Gene Ther 2007; 18: 423–434.

    Article  CAS  Google Scholar 

  16. Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009; 17: 1919–1928.

    Article  CAS  Google Scholar 

  17. Trobridge G, Vassilopoulos G, Josephson N, Russell DW . Gene transfer with foamy virus vectors. Methods Enzymol 2002; 346: 628–648.

    Article  CAS  Google Scholar 

  18. Zhang F, Thornhill SI, Howe SJ, Ulaganathan M, Schambach A, Sinclair J et al. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood 2007; 110: 1448–1457.

    Article  CAS  Google Scholar 

  19. Levasseur DN, Ryan TM, Pawlik KM, Townes TM . Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood 2003; 102: 4312–4319.

    Article  CAS  Google Scholar 

  20. Du Y, Jenkins NA, Copeland NG . Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005; 106: 3932–3939.

    Article  CAS  Google Scholar 

  21. Otsu M, Anderson SM, Bodine DM, Puck JM, O'Shea JJ, Candotti F . Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy. Mol Ther 2000; 1: 145–153.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Drs Adrian J Thrasher (University College London, London, UK) and David W Russell (University of Washington, Seattle, WA, USA) for sharing reagents, and the NIH Building 49 Animal Care Staff for excellent and humane care of laboratory animals. This research was supported by funding from the NHGRI intramural program and by a UNIL-CHUV research grant (to FC).

Author information

Authors and Affiliations

  1. Genetics and Molecular Biology Branch, National Human Genome Research Institute (NHGRI), Bethesda, MD, USA

    Y Ikawa, T Uchiyama, G J Jagadeesh & F Candotti

  2. Department of Pediatrics, Kanazawa University Hospital, Kanazawa, Japan

    Y Ikawa

  3. Department of Human Genetics, National Research Institute for Child Health and Development, Tokyo, Japan

    T Uchiyama

  4. Division of Immunology and Allergy, University Hospital of Lausanne, Lausanne, Switzerland

    F Candotti

Authors
  1. Y Ikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G J Jagadeesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F Candotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Candotti.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ikawa, Y., Uchiyama, T., Jagadeesh, G. et al. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors. Gene Ther 23, 815–818 (2016). https://doi.org/10.1038/gt.2016.51

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2016.51

Search

Advanced search

Quick links